Clinical trial
Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity
NCT03083431 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity
- Lead sponsor
- University of Zurich
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 22, 2022
- Completion date
- December 31, 2029
- Enrollment
- 276 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.